tiprankstipranks
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market
PSTV
Plus Therapeutics
RESEARCH TOOLSreports

Plus Therapeutics (PSTV) Financial Statements

Compare
1,706 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently $41.67M. The company's EPS TTM is $-0.033; its P/E ratio is -17.81; Plus Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 5.21M$ 5.82M$ 4.91M$ 224.00K$ 0.00
Gross Profit$ 4.77M$ 4.97M$ -4.78M$ -488.00K$ -66.00K
Operating Income$ -15.30M$ -14.70M$ -13.32M$ -19.71M$ -12.49M
EBITDA$ -14.85M$ -8.40M$ -12.69M$ -18.85M$ -12.05M
Net Income$ -22.39M$ -12.98M$ -13.32M$ -20.27M$ -13.40M
Balance Sheet
Cash & Short-Term Investments$ 8.76M$ 3.61M$ 8.55M$ 18.12M$ 18.40M
Total Assets$ 16.32M$ 6.63M$ 11.39M$ 23.87M$ 21.98M
Total Debt$ 821.00K$ 3.37M$ 4.18M$ 5.75M$ 6.99M
Net Debt$ -7.94M$ 3.29M$ -4.37M$ -12.37M$ -11.41M
Total Liabilities$ 12.33M$ 15.58M$ 12.74M$ 17.42M$ 11.14M
Stockholders' Equity$ 4.00M$ -8.95M$ -1.35M$ 6.45M$ 10.84M
Cash Flow
Free Cash Flow$ -20.84M$ -10.70M$ -13.01M$ -13.73M$ -10.42M
Operating Cash Flow$ -20.77M$ -10.55M$ -12.85M$ -12.97M$ -10.28M
Investing Cash Flow$ -854.00K$ -4.11M$ -160.00K$ -759.00K$ -82.00K
Financing Cash Flow$ 30.31M$ 6.19M$ 3.44M$ 13.45M$ 20.42M
Currency in USD

Plus Therapeutics Earnings and Revenue History

Income Statement >

Plus Therapeutics Debt to Assets

Balance Sheet >

Plus Therapeutics Cash Flow

Cash Flow >

Plus Therapeutics Forecast EPS vs Actual EPS

Earnings >